Arix Bioscience Plc/ GB00BD045071 /
2024-01-24 4:42:53 PM | Chg. - | Volume | Bid2023-12-05 | Ask2023-11-01 | High | Low |
---|---|---|---|---|---|---|
141.50GBX | - | 6,250 Turnover(GBP): 8,843.7500 |
-Bid Size: - | -Ask Size: - | 141.50 | 141.50 |
GlobeNewswire
2021-09-20
Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific Officer, strengthening scie...
GlobeNewswire
2021-07-27
Artios Announces $153 Million (£110 Million) Series C Financing Led by Omega Funds and TCG X
GlobeNewswire
2021-06-17
Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhib...
GlobeNewswire
2021-05-26
Bellerophon Appoints Naseem Amin, M.D. as Chairman of its Board of Directors
GlobeNewswire
2021-04-07
Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies
GlobeNewswire
2021-03-30
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
GlobeNewswire
2020-07-10
Atox Bio Announces a Positive Effect of Reltecimod on Resolution of Organ Dysfunction in Phase 3 ACC...
GlobeNewswire
2019-09-30
Sunstone announce new investment in immuno-oncology company STipe Therapeutics
GlobeNewswire
2019-02-26
Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical ...
GlobeNewswire
2018-06-08
T-Cell Immunotherapy Market, 2030 - Competitive Landscape Features a Mix of Established Players and ...
GlobeNewswire
2018-03-05
Artios exercises option to in-license potential first-in-class nuclease development programme
GlobeNewswire
2018-02-27
Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Result...
GlobeNewswire
2018-02-26
Artios Pharma Appoints Pierre Legault as Chairman of its Board of Directors
GlobeNewswire
2017-12-21
Arix Bioscience PLC: Arix Bioscience co-leads $30 million financing for Aura Biosciences
GlobeNewswire
2017-10-18
Arix Bioscience notes Harpoon Therapeutics' immuno-oncology collaboration with AbbVie